Top Chicago, IL Sales Companies With Best Stability & Growth (95)

Strong Revenue Growth: Recent announcements cite reaching $100M in contracted annual recurring revenue by the end of 2025. Deloitte’s 2025 Technology Fast 500 placement with high multi‑year growth reinforces momentum.

Investor Backing & Capital Strength: A $65M growth investment announced in December 2025, following earlier rounds, provides capital to accelerate expansion. Company statements link the funding to scaling adoption of AI agents in healthcare.

Strong Market Position & Advantage: Multiple recognitions (e.g., Deloitte Fast 500, Best in KLAS for Patient Communications) and claims of 1,000+ healthcare organizations and federal agencies using the platform point to durable market traction. Reported billions of annual patient‑provider communications further illustrate operating scale.

Strong Market Position & Advantage: Industry rankings place the company among top U.S. freight brokerages by gross revenue, while self-reported volumes (7,500+ daily loads) and a 4th‑largest truckload brokerage claim indicate durable competitive scale.

Market Expansion: New offices (e.g., Phoenix, Columbus, Minneapolis–St. Paul), a larger Chicago lease, and added cross‑border presence (e.g., Guadalajara, Toronto) signal deliberate geographic build‑out in key brokerage markets.

Cost & Operational Efficiency: Leadership highlights lower attrition and a notable productivity lift in 2024 with further gains targeted, alongside increased daily loads—signals of improved operating leverage through the cycle.

Strong Market Position & Advantage: Press and company materials describe PatientPoint as operating the largest U.S. digital point‑of‑care network (roughly 30,000 offices and 125,000 providers), reinforced by expanded MRC accreditation across its national screens in 2026. These signals support durable reach and verified delivery attractive to advertisers.

Product Line Growth: In March 2026, the company launched Health Audiences, adding programmatic buying access to point‑of‑care inventory aligned with the industry’s shift to data‑driven digital spend. This complements prior specialty additions and strengthens monetization options at the point of care.

Investor Backing & Capital Strength: In August 2025, Advent International signed a definitive agreement to acquire PatientPoint with the stated goal of accelerating network growth and product innovation. This sponsor commitment indicates access to capital and support for continued expansion.

Investor Backing & Capital Strength: The company secured a $100M strategic growth investment from Vista Equity Partners in 2022 to accelerate its next phase. Leadership additions in 2025–2026 are framed as positioning for AI‑powered growth.

Product Line Growth: The company acquired Projector PSA (now BigTime Enterprise PSA) in 2022 and later added Primetric (2023) and WorkRails (2024), expanding into enterprise PSA and services CPQ. Rebranding and integration updates through 2026 indicate a consolidated, broader suite.

Innovation-Driven Growth: Public release notes across 2025–2026 describe frequent updates, including AI‑powered resourcing, a conversational report builder, and an AI Expense Agent. Ongoing AI feature rollouts and a declared platform evolution point to sustained product velocity.

Strong Revenue Growth: Company and investor materials indicate annualized revenue above $200M (later cited above $300M) alongside annualized bookings exceeding $2.5B. These disclosures point to sustained, rapid top-line expansion over the past two years.

Profitability: The business reported reaching EBITDA break-even by the end of 2024, with later investor updates noting materially higher gross margins. This signals improving unit economics as scale and automation increase.

Investor Backing & Capital Strength: A $200M Series E in early 2025, which nearly doubled valuation to roughly $2.7B and coincided with the Yokoy acquisition, demonstrates strong access to growth capital. Independent coverage and investor confirmations underscore financing capacity to support expansion and product investment.

Strong Revenue Growth: Company communications report twelve consecutive quarters of year-over-year growth through late 2025 with momentum into early 2026. Leadership promotions and plans to expand the commercial team were tied to this trajectory.

Product Line Growth: The company launched OpenXSelect in 2025 and subsequently added features such as automated partner discounts and CTV attention targeting with TVision. It also introduced OpenXBuild in January 2026 to give advertisers more control and insights.

Market Expansion: “TV by OpenX” expanded internationally in 2024 to Australia, major European markets, Japan, and the UK, signaling scaling in CTV beyond the U.S. The firm also expanded regional presence and cited agency consolidation that explicitly included OpenX among key SSP partners.

Investor Backing & Capital Strength: A late-2025 Series B announcement described as oversubscribed by existing investors signals renewed runway and sponsor confidence. Company materials indicate the raise is intended to fund product development and go-to-market expansion into 2026.

Strong Hiring & Retention: LinkedIn activity and recent job ads indicate ongoing hiring across sales and engineering, with frequent team spotlights through 2026. Company pages depict an expanding employee base and active employer branding.

Market Expansion: New 2026 case studies and a steady blog cadence describe recent implementations across bulk-hauling niches and nationwide operations. Public posts highlight customer wins and sector-specific stories consistent with a scaling SaaS go-to-market.

Product Line Growth: Recent launches such as ALIS 500 benchmarking, the ALIS 500 Clinical Report, Ask ALIS (AI assistant), and ALIS HQ indicate active expansion of offerings. Release notes through 2025–2026 and new modules reflect a sustained shipping cadence.

Innovation-Driven Growth: AI and data initiatives (e.g., Ask ALIS and benchmarking built from hundreds of communities’ data) show investment in differentiated capabilities. Partners initially launching new workflows with ALIS further signal innovation pull.

Strategic Partnerships: Announced integrations with CarePredict and other ecosystem vendors, NIC MAP Vision certification, and an open‑API/app‑store approach point to a growing partner network. Support materials cite additional integrations consistent with deeper enterprise adoption.

Strong Revenue Growth: Annual revenue shows an upward trend across 2023–2024, and early-2025 reporting highlights a strong year-over-year increase alongside higher submission volume. Management also set an explicit near-term revenue growth target supported by a shift toward higher-margin services.

Strategic Partnerships: A large co-location partnership targets a broad physical footprint by end-2026, which can expand access to Medicare-eligible consumers. This is complemented by strategic moves aimed at dual-eligible populations and ecosystem adjacency.

Diversified Revenue Streams: Expansion beyond core Medicare brokerage is described through new subscription offerings and additional service lines such as telehealth/care coordination and product suite extensions. The acquisition of a home health agency also supports a broader, more integrated revenue mix over time.

Strong Market Position & Advantage: Ampersand is widely regarded as a leader within MVPD-based addressable and multiscreen TV, aggregating large operator inventory and deterministic data. Feedback suggests its AND Platform is a common buy-side tool for cross-screen planning and measurement across linear and streaming.

Market Expansion: The company indicates growing multiscreen household reach and deeper addressable coverage, complemented by national-plus-local selling and specialized political solutions. Recent cross-screen measurement and automation enhancements aim to capture shifting budgets in converged TV.

Strategic Partnerships: Ownership by major MVPDs and added alliances such as exclusive national addressable sales for additional operators expand supply and data access. These relationships support continued aggregation of linear and addressable inventory beyond its owner base.